BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2014
View Archived Issues
Novartis reflects on key developments of fourth quarter 2013
Read More
Preclinical validation of intranasal delivery of stem cell-based cancer therapeutics
Read More
Development of a novel genetic vaccine against viral-mediated respiratory disease
Read More
Pfizer reports topline results from PALOMA-1 trial in advanced breast cancer
Read More
Edison Pharmaceuticals' EPI-743 receives FDA orphan drug status for Friedreich's ataxia
Read More
NeuroPore Therapies begins preclinical development of lead treatment candidate
Read More
Cellceutix files trial protocol with FDA for novel antibiotic brilacidin
Read More
GSK-2140944 shows efficacy in in vitro and in vivo models of infection
Read More
Mitsubishi Tanabe Pharma profiles progress of third quarter of fiscal 2013
Read More
Phase II study demonstrates IRX-4204 to be well tolerated in patients with metastatic CRPC
Read More
Bayer and German Cancer Research Center form alliance against cancer
Read More
Bionor Pharma identifies potential biomarker for Vacc-4x treatment in HIV infection
Read More
FDA issues complete response letter for VersaFilm for acute migraine
Read More
Rockwell Medical completes phase III program for iron replacement drug Triferic
Read More
Euclises Pharmaceuticals presents novel NO-releasing coxibs
Read More
Nimbus Discovery patents new IRAK-4 inhibitors
Read More
Amarantus BioScience reports phase IIa data for eltoprazine in adult ADHD
Read More
Janssen R&D Ireland presents novel TLR7 agonists
Read More
Scientists at Bayer Schering Pharma divulge new AKR1C3 inhibitors
Read More
Valeant Pharmaceuticals to acquire PreCision Dermatology
Read More
Forest Laboratories' acquisition of Aptalis complete
Read More
bioTheranostics launches suite of genomic-based tests
Read More
Chiesi Farmaceutici acquires Cornerstone Therapeutics
Read More
Hawaii Biotech receives NIH grant for anthrax anti-toxin drugs
Read More
Sosei and FUJIFILM Pharma sign distribution agreement for Loramyc in Japan
Read More
Advanced Cancer Therapeutics launches phase I trial of ACT-PFK-158
Read More